In this regard, previous studies have shown that SGKs might modulate tumor growth via regulating cyclin D1 expression, GSK3-β/β-catenin cascade as well as epithelial-mesenchymal transition (EMT) in HCC cells [15, 30–32]. Here, GSK3B is linked to hepatocellular carcinoma.